glibenclamide

(redirected from Glynase)
Also found in: Dictionary.

glibenclamide

(glī-bĕn′klə-mīd′, -bĕng′-)
n.

glibenclamide

A SULPHONYLUREA drug, similar in action and effect to CHLORPROPAMIDE, and used to treat maturity onset (Type II) DIABETES. The drug is on the WHO official list. Brand names are Daonil, Euglucon, and Semi-daonil.

glibenclamide

References in periodicals archive ?
Generic name Brand name acetohexamide Dymelor chlorpropamide Diabinese glimepiride Amaryl glipizide Glucotrol, Glucotrol XL glyburide DiaBeta, Glynase, PresTab, Micronase tolazamide Tolinase tolbutamide Orinase
Generic name Trade name Mechanism of action Repaglinide Prandin [up arrow] Insulin secretion Sulfonylureas Amaryl [up arrow] Insulin secretion Glucotrol XL Glynase [alpha]-Glucosidase Precose Delays digestion and absorption of complex inhibitors Glyset carbohydrates Metformin Glucophage Insulin sensitizes (liver > muscle) Thiazolidinedione Rezulin Insulin sensitizes (Troglitazone) (muscle > liver) Effects on glycemia Generic name FPG, (a) mg/L [HbA.
A generic version of Pharmacia & Upjohn's Glynase, used as an adjunct to diet to lower the blood glucose in patients with noninsulin-dependent diabetes mellitus (Type II), is now offered by Novopharm USA, Schaumburg, Ill.
Glyburide (DiaBeta, Micronase, Glynase PresTab): Starting doses, Nonmicronized -2.
Find Your Diabetes Medicines(*) Sulfonylureas Amaryl DiaBeta Diabinese Dymelor Glucotrol Glucotrol XL Glynase PresTab Micronase Orinase Tolinase Biguanides Glucophage Alpha-glucosidase Inhibitors Glyset Precose Thiazolidinediones Rezulin Meglitinides: Prandin Insulins Lispro (Humalog) Regular Premixed Ultralente NPH or Lente
For example, the pharmaceutical firm publishes A Path to Healthy Living, which is a patient education kit for people taking Glynase PrestTab tablets (people with type II diabetes).
Glyburide (Micronase[R], Diabeta[R], Glynase PresTab[R]), glypizide (Glucotrol[R]), and glimepride (Amaryl[R]) are the second generation sulfonylureas.
Pharmacists were paid for counseling type II diabetes patients who, in consultation with their physicians, had transferred from Upjohn's Micronase tablets to its Glynase PresTab tablets.
The Diabetes-related drugs included in the analysis were: Actos (pioglitazone), Amaryl (glimepiride), Avandia (rosiglitazone), Byetta (eventide), DiaBeta (glyburide), Glucophage (metformin), Glucovance (glyburide and metformin), Glynase (glyburide), Glyset (miglitol), Humalog (insulin lispro), Insulin Isophane, Invokana (canaglifozin), Januvia (sitagliptin), Kazano (alogliptin and metformin), Lantus (insulin glargine), Nesina (alogliptin), NovoLog (insulin aspart), Onglyza (saxagliptin), Oseni (alogliptin0.